hotspot -WSS

hotspot

author：hotspot 2025-08-31 01:58:13 - browse：52

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Delta passengers in Vegas fall sick while waiting on flight in triple

WSS

After a decade, new Gardasil ad campaign gets it (mostly) right

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Hormonal contraceptives don’t actually treat endometriosis

Humana CEO Bruce Broussard to step down in 2024

Better Therapeutics data on benefit with GLP

Wikipedia

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Female surgeons have lower rates of long

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Peter Marks talks Operation Warp Speed for Rare Diseases

Alkermes shareholders re

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: Merger Mondays, Ozempic panic

Moonlake's readout produced a cash windfall. Risks remain

European regulators recommend Amylyx's ALS drug be rejected

hotspot

What's changing in Medicare's open enrollment this year?

After a decade, new Gardasil ad campaign gets it (mostly) right

Stanford president’s abrupt resignation sparks debate

US jobless claims fall again as labor market continues to flash strength

Takeaways from AdvaMed, the largest medical devices conference

Better Therapeutics data on benefit with GLP

hotspot

entertainment

explore

Wikipedia